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Abstract
Pulmonary artery aneurysm in adults is a rare diagnosis. Most cases described in the literature are either associated with congenital heart
disease or pulmonal arterial hypertension, respectively, or are not true aneurysms but rather pseudoaneurysms, which are usually iatro-
genic. We present the case of a 68-year old female patient with the incidental ﬁnding of a true aneurysm of the right peripheral pulmonary
artery with a maximum diameter of 4 cm. With increasing aneurysm diameter over time, the decision for a surgical resection was made.
Complete resection of the aneurysm including lower lobe resection was performed. Histopathological examination showed necrotizing
giant cell arteritis as the underlying cause. The postoperative course was uneventful and no signs of further disease activity were detected.
To our knowledge, this is the ﬁrst reported case of a pulmonary artery aneurysm caused by giant cell arteritis, whereas it should be noted
that the distinction between Takayasu arteritis and giant cell arteritis is not clearly deﬁned. Considering the high mortality associated with
aneurysm rupture, surveillance is advocated for small aneurysms, whereas for larger aneurysms and those showing signs of progression
in size despite medical therapy or even dissection, surgical intervention should be considered.
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INTRODUCTION
An aneurysm of the pulmonary artery (PAA) is a rare ﬁnding. In
general PAA can be subdivided into true aneurysms, showing dila-
tation of all three layers of the vessel wall, and pseudoaneurysms.
True PAA are often associated with either congenital heart disease,
or are so-called ‘acquired’, resulting from pulmonary hypertension,
inﬂammation, infection, neoplasm or connective-tissue disease.
What these aneurysms have in common is a certain risk of dis-
section or even rupture, which often results in imminent death.
Because this risk varies with the localization, size and underlying
cause, early detection and adequate treatment are crucial in order
to prevent high mortality rates.
CASE REPORT
We present the case of a 68-year old female patient who initially
presented with symptoms of pneumonia to her family physician.
Chest X-ray showed the incidental ﬁnding of an unclear circular
mass in the right parahilar region. Computed tomography (CT)
scan revealed an aneurysm of the right pulmonary artery, distal to
the middle lobe arteries, with a maximum diameter of 3 cm. As
the patient was completely asymptomatic and echocardiography
showed no signs of pulmonary arterial hypertension, the follow-
up CT scan was performed with some delay (patient reasons),
after 4 years. As a progression of the aneurysm diameter to 4 cm
was documented (Fig. 1), the patient was referred to our depart-
ment for further treatment. Neither an iatrogenic trauma (i.e.
heart catheterization), nor clinical signs of a temporal arteritis
could be elicited.
Especially because of the increasing aneurysm size, which now
was more than double the normal vessel diameter in this region,
the decision for a surgical approach in this asymptomatic patient
was made.
On operation, resection and primary reconstruction of the pul-
monary artery was not feasible due to the gap in diameter of the
vessel in the pre- and postaneurysmatic region, where the aneur-
ysm was expanding into the segmental arteries. Thus, complete
resection of the aneurysm including anatomic lower lobe resection
was performed (Fig. 1). The postoperative course was uneventful.
Histopathological examination showed necrotizing giant cell arter-
itis (GCA) as the underlying cause for this true PAA (Fig. 2). Taking a
potentially generalized disease activity into account, a positron
emission tomography was performed in the postoperative course,
which did not reveal further foci of inﬂammation. Since no clinical
signs of a temporal arteritis (i.e. headaches, jaw claudication, diplo-
pia or visual loss) were present and erythrocyte sedimentation rates
as well as C-reactive protein (CRP) levels were normal in the
preoperative period as well as on the follow-up, biopsy of the
temporal artery was not indicated. Implying curative surgery,
steroid therapy was thus considered abdicable.
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DISCUSSION
Of the few reported PAA cases in the literature, >50% are
described as being associated with congenital heart disease, in-
cluding patent ductus arteriosus, ventricular septal defect or bi-
cuspid aortic valve. However, the sequelae of surgical repair of the
aforementioned and other congenital heart pathologies can also
be the cause of PAA. In the other half of cases, acquired patholo-
gies are found to be the underlying cause of disease. These
include pulmonary arterial hypertension, vasculitis (i.e. Behçet’s
disease), infection, neoplasm, connective tissue disease (i.e. Marfan
syndrome) or trauma (including iatrogenic injuries) [1, 2]. The clin-
ical signs and symptoms are inconsistent and non-speciﬁc, since
patients may not be symptomatic at all or present with dyspnoea
on exertion, cough, chest pain or even haemoptysis. On occasion,
the symptoms of a pulmonary embolism (PE) may ﬁnally result
in the diagnosis of PAA, associated with PE. It is assumed, that
PAA also underlie Laplace’s law in the lower pressure pulmonary
circuit, with haemodynamic forces (i.e. pulmonary hypertension)
promoting PAA-diameter progression, and thus increasing the risk
of dissection or rupture [1]. Inayama et al. [2] highlighted a mortal-
ity rate for PAA of 86.5%, as a rupture of the pulmonary artery wall
causes haemopericardium or bleeding into the pleural cavity,
leading to a sudden death in most cases. However, because of the
rarity of PAA and the diversity of underlying causes, no standar-
dized clinical management and treatment guidelines for PAA have
been established yet.
In the presented case, even though clinical manifestations of
any infection or inﬂammatory process were absent and preopera-
tive CRP-levels were not elevated, histopathological analysis
revealed necrotizing GCA to be the cause of the aneurysm. For
Takayasu arteritis (TA), only a few cases involving the pulmonary
artery have been described, but this is the ﬁrst report of an aneur-
ysm of the peripheral PA due to GCA [3].
Whereas TA predominantly affects the aorta and its major
branches in young women, GCA is primarily a disease of the
elderly, affecting middle- to small-sized arteries. Inﬂammatory
inﬁltrates of lymphocytes, giant cells and ﬁbrosis can be found in
both diseases, but large numbers of giant cells are typically found
in CGA.
Nevertheless, it should be noted that both diseases do overlap,
concerning clinical and histopathological ﬁndings, and that only a
combination of both aspects can lead to diagnosis. Some authors
even suggest that both diseases may not be distinct entities, but
rather represent different phenotypes of the same disorder [4]. In
our case, the localization of the disease, histopathology and the
patients’ age make GCA the most probable diagnosis, but man-
agement options would have been the same for both pathologies.
In PAA, early diagnosis and treatment are crucial as only few
cases of surviving patients with ruptured pulmonary artery aneur-
ysms are described [2]. A cut-off in diameter, indicating an increas-
ing risk for severe complications, such as dissection or rupture, has
not been deﬁned yet. As a reference, Fraser et al. [5] described the
upper limit of the normal diameter of the main pulmonary artery
to be29 mm and for the right interlobar artery,17 mm.
In our opinion, active surveillance by annual CT scans is ad-
equate for small aneurysms, whereas for larger aneurysms
(exceeding double the size of the normal vessel diameter) and
aneurysms progressing in size despite medical therapy (i.e. corti-
costeroids), or even dissection, surgical intervention is inevitable.
In these cases, surgery appears to be the treatment of choice,
being diagnostic and curative.
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Figure 2: Necrotizing giant cell arteritis of the pulmonary artery: note the giant
cells (arrows) and the attendant lymphohistocytic inﬁltrate (*) with foci of ne-
crosis and ﬁbrosis of the vessel wall (hematoxylin and eosin staining, 10×)
Figure 1: Intraoperative view of the interlobar region with exposure of the pul-
monary artery aneurysm. Insert: CT-scan showing aneurysm of the right pul-
monary artery measuring 4.1 × 3.9 cm
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